logo

For the Inventor, By the Inventor

Uppsala, Sweden

Kabi Pharmacia Ab

Calculating rank
USPTO Granted Patents = 27


Forward Citations = 671

Loading Chart...
Loading Chart...

61 inventors (with patents filed for the assignee):

goldMedal Bahram Resul (6 out of 23 patents)

silverMedal Johan W Stjernschantz (6 out of 28 patents)

bronzeMedal Stephen S Chang (2 out of 25 patents)

4.  Kejian J Wu (2 out of 2 patents)

5.  Per Holm (1 out of 36 patents)

6.  Peter David Gluckman (1 out of 29 patents)

7.  Dimitrios Karussis (1 out of 2 patents)

8.  Oded Abramsky (1 out of 4 patents)

9.  Shimon Slavin (1 out of 24 patents)

10.  Tibor Szabo (1 out of 19 patents)

11.  Pär Gellerfors (1 out of 10 patents)

12.  Lars-Inge Olsson (1 out of 7 patents)

13.  Rainer Eketorp (1 out of 4 patents)

14.  Gyula Dalmadi (1 out of 5 patents)

15.  Istvan Hermecz (1 out of 47 patents)


Core Competencies:
Solid Lipid Particles
Bioactive Agents
Linomide
Recombinant Factor VIII
Prostaglandin Derivatives
Drug Formulation
Intravaginal Devices
Multi-Dose Syringe
Antioxidant Complex
Ocular Implants
Gastric Disorders
Amino Salicylic Acid

27 patents:

1. 6207178 - Solid lipid particles, particles of bioactive agents and methods for the manufacture and use thereof (2001-03-27),
2. 5691350 - Use of linomide for treatment of retrovirus infections specifically HIV (1997-11-25),
3. 5661008 - Recombinant human factor VIII derivatives (1997-08-26),
4. 5618817 - Use of diphenylbutyl-piperazinecarboxamides in the treatment of (1997-04-08),
5. 5580882 - Use of substituted quinoline carboxamide (1996-12-03),
6. 5516796 - Thioprostaglandins and -prostaglandin-like compounds and therapeutic (1996-05-14),
7. 5505966 - Therapeutical composition and process for its preparation (1996-04-09),
8. 5476667 - Method for drug formulation and a pharmaceutical composition (1995-12-19),
9. 5466833 - Process for the preparation of (1995-11-14),
10. 5422369 - Prostaglanddin derivatives for the treatment of glaucoma or ocular (1995-06-06),
11. 5422368 - Prostaglandin derivatives for the treatment of glaucoma or ocular (1995-06-06),
12. 5321128 - Prostaglandin derivatives for the treatment of glaucoma or ocular (1994-06-14),
13. 5302718 - Compounds containing an amino salicylic acid moiety linked to a (1994-04-12),
14. 5276014 - Treatment of human lactation failure (1994-01-04),
15. 5273966 - O-glycosylated IGF-1 (1993-12-28),
Company Overview
Kabi Pharmacia AB, based in Uppsala, Sweden, specializes in the development and manufacturing of pharmaceutical products, particularly in the areas of intravenous therapies and nutritional solutions. The company is committed to enhancing patient care through innovative drug delivery systems and high-quality medical products. With a focus on research and development, Kabi Pharmacia aims to address critical healthcare needs and improve treatment outcomes across various therapeutic areas, contributing to the global healthcare landscape.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

27 Patents

#15 in Uppsala

#255 in Sweden

#24,046 in the World

Uppsala, SE
Uppsala, Sweden

Kabi Pharmacia Ab

Forward Citations = 671

61 inventors:

goldMedal Bahram Resul (6 out of 23 patents)

silverMedal Johan W Stjernschantz (6 out of 28 patents)

bronzeMedal Stephen S Chang (2 out of 25 patents)

4.  Kejian J Wu (2 out of 2 patents)

5.  Per Holm (1 out of 36 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Kabi Pharmacia Ab. Retrieved from https://idiyas.com/company/kabi-pharmacia-ab

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…